Scientists are refining electroporation methods to improve CRISPR/Cas9 gene editing efficiency while preserving cell health. By adjusting buffer composition, pulse parameters, and delivery formats, ...
If programmable CRISPR protocols allow a lab to go from patient biopsy to edited pluripotent line and differentiated cells in a matter of weeks, those oversight mechanisms will need to adapt so they ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.